These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21266541)

  • 1. Expression, purification, and functional characterization of recombinant PTD-SARA.
    Huang C; Du R; Zhang P; Meng H; Jia H; Song Y; Li M; Zhang Y; Sun S
    Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):110-7. PubMed ID: 21266541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
    Zhao BM; Hoffmann FM
    Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endofin acts as a Smad anchor for receptor activation in BMP signaling.
    Shi W; Chang C; Nie S; Xie S; Wan M; Cao X
    J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARA is dispensable for functional TGF-β signaling.
    Bakkebø M; Huse K; Hilden VI; Forfang L; Myklebust JH; Smeland EB; Oksvold MP
    FEBS Lett; 2012 Sep; 586(19):3367-72. PubMed ID: 22819827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression.
    Kunzmann S; Wohlfahrt JG; Itoh S; Asao H; Komada M; Akdis CA; Blaser K; Schmidt-Weber CB
    FASEB J; 2003 Feb; 17(2):194-202. PubMed ID: 12554698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARA expression in high glucose induced epithelium to mesenchymal transition of proximal tubule cells].
    Tang W; Ling G; Sun L; Peng Y; Liu Y; Liu H; Xiao L; Duan S; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1230-5. PubMed ID: 21200089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
    Wang QL; Yuan JL; Tao YY; Zhang Y; Liu P; Liu CH
    J Ethnopharmacol; 2010 Feb; 127(3):631-40. PubMed ID: 20015471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad Anchor for Receptor Activation Regulates High Glucose-Induced EMT via Modulation of Smad2 and Smad3 Activities in Renal Tubular Epithelial Cells.
    Tang WB; Ling GH; Sun L; Zhang K; Zhu X; Zhou X; Liu FY
    Nephron; 2015; 130(3):213-20. PubMed ID: 26159183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
    Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
    Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1918-23. PubMed ID: 17923018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway.
    Shibata S; Marushima H; Asakura T; Matsuura T; Eda H; Aoki K; Matsudaira H; Ueda K; Ohkawa K
    Int J Oncol; 2009 May; 34(5):1433-48. PubMed ID: 19360357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient method for expression in Escherichia coli and purification of the extracellular ligand binding domain of the human TGFbeta type II receptor.
    Gasparian ME; Elistratov PA; Yakimov SA; Dolgikh DA; Kirpichnikov MP
    J Biotechnol; 2010 Jul; 148(2-3):113-8. PubMed ID: 20451568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.